Anti-inflammatory androstane derivative
US6759398B2 · kind B2 · utility
21Cited by
41References
18Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 4, 2002 |
| Grant date | Jul 6, 2004 |
| Priority date | — |
| Expiry date | Jul 29, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
According to one aspect of the invention, there is provided a pharmaceutical formulation for administration by inhalation comprising a compound of formula (I), or a solvate thereof, together with a long-acting &bgr;2-adrenoreceptor agonist which formulation has a therapeutically useful effect in the treatment of inflammatory disorders of the respiratory tract over a period of 24 hours or more.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.